CN104789569A - DNA (Deoxyribose Nucleic Acid) aptamer for detecting grouper iridovirus infection, as well as screening method and application of DNA aptamer - Google Patents
DNA (Deoxyribose Nucleic Acid) aptamer for detecting grouper iridovirus infection, as well as screening method and application of DNA aptamer Download PDFInfo
- Publication number
- CN104789569A CN104789569A CN201510125806.8A CN201510125806A CN104789569A CN 104789569 A CN104789569 A CN 104789569A CN 201510125806 A CN201510125806 A CN 201510125806A CN 104789569 A CN104789569 A CN 104789569A
- Authority
- CN
- China
- Prior art keywords
- library
- screening
- cell
- dna
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012216 screening Methods 0.000 title claims abstract description 59
- 108020004414 DNA Proteins 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 30
- 102000053602 DNA Human genes 0.000 title claims abstract description 25
- 108091008102 DNA aptamers Proteins 0.000 title claims description 13
- 241000593470 Grouper iridovirus Species 0.000 title claims description 10
- 208000015181 infectious disease Diseases 0.000 title claims description 9
- 108091023037 Aptamer Proteins 0.000 title description 4
- 108091008104 nucleic acid aptamers Proteins 0.000 claims abstract description 40
- 239000006228 supernatant Substances 0.000 claims abstract description 32
- 230000027455 binding Effects 0.000 claims abstract description 18
- 108020004682 Single-Stranded DNA Proteins 0.000 claims abstract description 10
- 210000004027 cell Anatomy 0.000 claims description 91
- 241000700605 Viruses Species 0.000 claims description 16
- 239000011324 bead Substances 0.000 claims description 12
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 11
- 238000012408 PCR amplification Methods 0.000 claims description 9
- 230000003321 amplification Effects 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 108010090804 Streptavidin Proteins 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 241000701372 Iridovirus Species 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 210000004988 splenocyte Anatomy 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims description 2
- 229960005156 digoxin Drugs 0.000 claims description 2
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 239000007853 buffer solution Substances 0.000 claims 2
- -1 carboxyl tetramethylrhodamine Chemical compound 0.000 claims 2
- 238000013016 damping Methods 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 241000321428 Epinephelus guttatus Species 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229930003756 Vitamin B7 Natural products 0.000 claims 1
- 238000005576 amination reaction Methods 0.000 claims 1
- 230000012447 hatching Effects 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011735 vitamin B7 Substances 0.000 claims 1
- 235000011912 vitamin B7 Nutrition 0.000 claims 1
- 241001417495 Serranidae Species 0.000 abstract description 29
- 230000009385 viral infection Effects 0.000 abstract description 7
- 230000002441 reversible effect Effects 0.000 abstract description 2
- 238000001514 detection method Methods 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 238000000684 flow cytometry Methods 0.000 description 8
- 210000005228 liver tissue Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 239000012148 binding buffer Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 230000009870 specific binding Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000007885 magnetic separation Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000013076 target substance Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000012917 library technology Methods 0.000 description 1
- 239000006148 magnetic separator Substances 0.000 description 1
- 238000009364 mariculture Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开一种用于检测石斑鱼虹彩病毒感染的DNA核酸适配体及其筛选方法和应用。在每轮筛选过程中,引入两次反筛的步骤,首先将前一轮的单链DNA文库与正常细胞结合,以去除与正常石斑鱼细胞结合的非特异ssDNA,然后将上清与被石斑鱼虹彩病毒感染的细胞进行结合筛选,从被石斑鱼虹彩病毒感染的细胞上分离得到的ssDNA,然后再和正常细胞结合,分离得到上清。PCR扩增文库制备出单链的DNA文库。重复以上的筛选流程,与第一轮筛选的正常细胞数目相比,将筛选过程中正常细胞的数目提高2-6倍,与第一轮筛选的文库与细胞的结合时间相比,在随后的筛选过程中,文库与正常细胞结合时间从0.5h增加至1h,文库与病毒感染细胞结合时间从1h缩短至0.5h,以提高每轮的筛选效率。
The invention discloses a DNA nucleic acid aptamer for detecting grouper iridescent virus infection, a screening method and application thereof. During each round of screening, two steps of reverse screening were introduced. First, the single-stranded DNA library of the previous round was combined with normal cells to remove non-specific ssDNA combined with normal grouper cells, and then the supernatant was combined with the normal cells. The grouper iridovirus-infected cells were combined for screening, the ssDNA isolated from the grouper iridovirus-infected cells was combined with normal cells, and the supernatant was obtained. PCR amplifies the library to prepare a single-stranded DNA library. Repeat the above screening process, compared with the number of normal cells in the first round of screening, increase the number of normal cells in the screening process by 2-6 times, compared with the binding time of the library and cells in the first round of screening, in the subsequent During the screening process, the binding time between the library and normal cells was increased from 0.5h to 1h, and the binding time between the library and virus-infected cells was shortened from 1h to 0.5h to improve the screening efficiency of each round.
Description
技术领域:Technical field:
本发明属于分子生物学领域,具体涉及一种可用于细胞水平和组织水平上石斑鱼虹彩病毒(SGIV)感染检测的DNA核酸适配体及其筛选方法和应用。The invention belongs to the field of molecular biology, and in particular relates to a DNA nucleic acid aptamer which can be used for detection of grouper iridescent virus (SGIV) infection at the cell level and tissue level, and a screening method and application thereof.
背景技术:Background technique:
核酸适配体是由指数富集的配基系统进化技术(SELEX)筛选得到的一类新型检测和治疗工具。指数富集的配基系统进化技术是一类广受关注的新型检测和治疗的生物文库技术。它利用人工合成的、容量约为1014~1015的随机寡核苷酸文库与靶物质结合,经过多轮筛选获得靶物质的核酸适配体。利用该技术筛选得到的核酸适配体具有与单克隆抗体相当的高特异性和高亲和性,由于筛选是在体外进行的化学过程,所以从金属离子、有机染料等简单体系,到病毒、细胞、组织等复杂体系,均可作为筛选对象,而且核酸适配体没有免疫原性,温度变化引起的变性是可逆的,筛选时间短费用低,得到的核酸适配体易于合成和修饰。因此,核酸适配体不仅在新药研发领域具有广阔前景而引人瞩目,其在重大疾病的生物医学基础研究、疾病诊断领域同样显示出广阔的应用前景。Nucleic acid aptamer is a new type of detection and treatment tool screened by exponential enrichment ligand system evolution (SELEX). Ligand system evolution technology with exponential enrichment is a kind of biological library technology for novel detection and treatment that has attracted wide attention. It uses artificially synthesized random oligonucleotide library with a capacity of about 10 14 to 10 15 to bind to the target substance, and obtains the nucleic acid aptamer of the target substance after multiple rounds of screening. The nucleic acid aptamers screened by this technology have high specificity and high affinity comparable to monoclonal antibodies. Since the screening is a chemical process in vitro, simple systems such as metal ions and organic dyes, to viruses, Complex systems such as cells and tissues can be used as screening objects, and nucleic acid aptamers are not immunogenic, denaturation caused by temperature changes is reversible, screening time is short and the cost is low, and the obtained nucleic acid aptamers are easy to synthesize and modify. Therefore, nucleic acid aptamers not only have broad prospects in the field of new drug research and development, but also show broad application prospects in the fields of biomedical basic research and disease diagnosis of major diseases.
我国是水产养殖大国,石斑鱼是最名贵的海水养殖鱼类之一,具有极高经济价值。然而,近年来在石斑鱼中暴发和流行的虹彩病毒等严重地威胁了石斑鱼的海水养殖,造成了巨大的经济损失。目前国际上在水产动物疾病,包括石斑鱼虹彩病毒快速诊断的方法主要包括基于细菌学、病毒学、寄生虫学及组织病理学的传统方法,基于抗体的免疫学检测方法,针对特异性病原的抗体的血清学检测技术以及分子生物学技术等。这些方法各有优点同时也存在严重不足,所以必须着力开发新型的、特异性更强、灵敏性更高、操作更简便的核酸适配体来检测和控制石斑鱼虹彩病毒(SGIV)感染。my country is a big country in aquaculture, and grouper is one of the most valuable marine fishes with high economic value. However, the outbreak and prevalence of iridescent virus in grouper in recent years has seriously threatened the mariculture of grouper and caused huge economic losses. At present, the international rapid diagnosis methods for aquatic animal diseases, including grouper iridescent virus, mainly include traditional methods based on bacteriology, virology, parasitology and histopathology, and antibody-based immunological detection methods for specific pathogens. Antibody serological detection technology and molecular biology technology, etc. These methods have their own advantages and serious shortcomings, so efforts must be made to develop new nucleic acid aptamers with stronger specificity, higher sensitivity, and easier operation to detect and control grouper iridescent virus (SGIV) infection.
发明内容:Invention content:
本发明的第一个目的是提供一种高特异性、高灵敏度、无免疫原性、稳定易修饰、便于合成和保存的用于检测石斑鱼虹彩病毒感染的DNA核酸适配体。The first object of the present invention is to provide a DNA nucleic acid aptamer for detecting grouper iridescent virus infection with high specificity, high sensitivity, non-immunogenicity, stability and easy modification, and convenient synthesis and storage.
本发明的用于检测石斑鱼虹彩病毒感染的DNA核酸适配体,其核苷酸序列如SEQ IDNO:1所示,所述的核苷酸序列上结合有用于检测的标记。The DNA nucleic acid aptamer for detecting grouper iridovirus infection of the present invention has a nucleotide sequence as shown in SEQ ID NO: 1, and a marker for detection is bound to the nucleotide sequence.
上述DNA核酸适配体,其核苷酸序列上的任一位置可以被磷酸化、甲基化、氨基化、疏化或同位素化。Any position on the nucleotide sequence of the above-mentioned DNA nucleic acid aptamer can be phosphorylated, methylated, aminated, thinned or isotoped.
所述的用于检测的标记优选为:异硫氰酸荧光素(FITC)、羧基四甲基罗丹明(TAMRA)、生物素、地高辛、荧光物质、纳米发光材料、聚乙二醇、肽段、蛋白、叶酸或酶标记。The label used for detection is preferably: fluorescein isothiocyanate (FITC), carboxytetramethylrhodamine (TAMRA), biotin, digoxin, fluorescent substances, nano-luminescent materials, polyethylene glycol, Peptide, protein, folic acid or enzyme labeling.
上述DNA核酸适配体,不论是经部分取代或者经过修饰后,都具有与原核酸适配体基本相同或者类似的分子结构、理化性质和功能,都可用于石斑鱼虹彩病毒(SGIV)检测。The above-mentioned DNA aptamers, whether partially substituted or modified, have basically the same or similar molecular structure, physical and chemical properties and functions as the original aptamers, and can be used for the detection of grouper iridescent virus (SGIV) .
本发明的第二个目的提供一种上述DNA核酸适配体的筛选方法,其特征在于,包括以下步骤:The second object of the present invention provides a kind of screening method of above-mentioned DNA nucleic acid aptamer, it is characterized in that, comprises the following steps:
(1)、合成以下随机单链DNA文库和引物:(1), synthesize the following random single-stranded DNA library and primers:
随机文库Library50:Random library Library50:
5’-GACGCTTACTCAGGTGTGACTCG(50N)CGAAGGACGCAGATGAAGTCTC5'-GACGCTTACTCAGGTGTGACTCG(50N)CGAAGGACGCAGATGAAGTCTC
5’引物:5’-FITC-GACGCTTACTCAGGTGTGACTCG-3’;5' primer: 5'-FITC-GACGCTTACTCAGGTGTGACTCG-3';
5’引物:5’-TAMRA-GACGCTTACTCAGGTGTGACTCG-3’;5' primer: 5'-TAMRA-GACGCTTACTCAGGTGTGACTCG-3';
3’引物:5’-Biotin-GAGACTTCATCTGCGTCCTTCG-3’;3' primer: 5'-Biotin-GAGACTTCATCTGCGTCCTTCG-3';
(2)、Cell-SELEX筛选流程:用石斑鱼虹彩病毒感染正常的石斑鱼脾细胞GS细胞,细胞继续培养48h,去除培养基后用缓冲液洗涤被感染的GS细胞,将步骤(1)中的随机文库溶解后首先与正常GS细胞在冰上孵育结合0.5h得到上清,然后将上清与被感染的GS细胞进行孵育结合1h,孵育完成后去除液体并用缓冲液洗涤GS细胞,然后将洗涤后的GS细胞于85~94℃加热2~10min,离心得到上清1,将上清1与正常的GS细胞在冰上孵育结合,用与得到上清1相同的方法得到上清2,即为被虹彩病毒感染的GS细胞的特异性核酸适配体文库;(2), Cell-SELEX screening process: Infect normal grouper splenocyte GS cells with grouper iridescent virus, the cells continue to be cultivated for 48h, wash the infected GS cells with buffer after removing the culture medium, and step (1 After dissolving the random library in ), first incubate with normal GS cells on ice for 0.5h to obtain the supernatant, then incubate the supernatant with infected GS cells for 1h, remove the liquid after incubation and wash the GS cells with buffer, Then heat the washed GS cells at 85-94°C for 2-10 minutes, centrifuge to obtain supernatant 1, incubate supernatant 1 with normal GS cells on ice, and obtain supernatant in the same way as supernatant 1 2. It is the specific nucleic acid aptamer library of GS cells infected by iridovirus;
(3)、文库扩增:利用步骤(1)中的合成的引物对步骤(2)中筛选得到的特异性核酸适配体文库进行PCR扩增,得到扩增产物双链DNA;(3), library amplification: utilize the synthetic primer in step (1) to carry out PCR amplification to the specific nucleic acid aptamer library screened in step (2), obtain double-stranded DNA of amplified product;
(4)、DNA单链文库的制备:将链酶亲和素标记的磁珠与步骤(3)中的双链DNA在常温下孵育,利用双链DNA上的标记与磁珠上链酶亲和素的亲和作用,将双链DNA结合到磁珠表面,在磁珠中加入碱液反应后,回收得到上清液,将上清液通过除盐柱收集到含有DNA单链文库的溶液;(4) Preparation of single-stranded DNA library: Incubate the streptavidin-labeled magnetic beads with the double-stranded DNA in step (3) at room temperature, and use the label on the double-stranded DNA to bind the streptavidin on the magnetic beads. Binding double-stranded DNA to the surface of magnetic beads, adding lye to the magnetic beads to react, recovering the supernatant, and collecting the supernatant through a desalting column to a solution containing a DNA single-stranded library ;
(5)、重复多轮筛选:将步骤(4)中收集的DNA单链文库代替步骤(2)中的随机文库,重复以上步骤(2)-(4)至少14次,与第一轮筛选的正常细胞数目相比,将筛选过程中正常GS细胞的数目提高2-6倍,与第一轮筛选的文库与细胞的结合时间相比,在随后的筛选过程中,文库与正常GS细胞结合时间从0.5h增加至1h,文库与病毒感染细胞结合时间从1h缩短至0.5h,以提高每轮的筛选效率,即得到用于检测石斑鱼虹彩病毒感染的DNA核酸适配体。(5), repeat multiple rounds of screening: replace the random library in step (2) with the DNA single-stranded library collected in step (4), repeat the above steps (2)-(4) at least 14 times, and the first round of screening Compared with the number of normal cells, the number of normal GS cells in the screening process is increased by 2-6 times. Compared with the binding time of the library and cells in the first round of screening, in the subsequent screening process, the library is combined with normal GS cells The time was increased from 0.5h to 1h, and the binding time between the library and virus-infected cells was shortened from 1h to 0.5h, so as to improve the screening efficiency of each round, that is, to obtain DNA aptamers for detecting grouper iridovirus infection.
优选,步骤(2)中所述的培养基为L15培养基。Preferably, the medium described in step (2) is L15 medium.
优选,步骤(2)中所述的缓冲液为PBS缓冲液。Preferably, the buffer described in step (2) is PBS buffer.
优选,步骤(3)中所述的PCR扩增,其扩增体系为1000μl:10×buffer 100μl,dNTP(2.5mM)80μl,模板100μl,5’引物30μl,3’引物30μl,rTaq酶10μl,dsH2O 650μl;扩增程序为:94℃2min,94℃1min,60℃30sec,72℃1min,经过12轮循环,72℃5min。Preferably, for the PCR amplification described in step (3), the amplification system is 1000 μl: 10×buffer 100 μl, dNTP (2.5mM) 80 μl, template 100 μl, 5’ primer 30 μl, 3’ primer 30 μl, rTaq enzyme 10 μl, dsH 2 O 650μl; amplification program: 94°C for 2min, 94°C for 1min, 60°C for 30sec, 72°C for 1min, after 12 cycles, 72°C for 5min.
步骤(4)中所述的回收得到上清液,优选通过磁性分离架回收。The supernatant obtained in the recovery described in step (4), is preferably recovered by a magnetic separation rack.
本发明的第三个目的是提供一种用于检测石斑鱼虹彩病毒感染的试剂盒,其特征在于,含有上述SEQ ID NO:1所示的DNA核酸适配体。A third object of the present invention is to provide a kit for detecting grouper iridescent virus infection, which is characterized in that it contains the DNA nucleic acid aptamer shown in the above SEQ ID NO: 1.
本发明的第四个目的是提供上述用于检测石斑鱼虹彩病毒感染的DNA核酸适配体在进行石斑鱼虹彩病毒的感染检测中的应用。The fourth object of the present invention is to provide the application of the above-mentioned DNA nucleic acid aptamer for detecting grouper iridescent virus infection in the detection of grouper iridescent virus infection.
本发明将随机DNA单链文库首先与正常细胞在冰上孵育后,回收到的上清1与被病毒感染的GS细胞在冰上孵育,收集感染细胞高温变性回收到上清2后,再次与正常细胞冰上孵育,从而最大限度地去除与正常细胞结合的非特异单链DNA,实现提高筛选效率的目的。In the present invention, the random DNA single-stranded library is first incubated with normal cells on ice, and then the recovered supernatant 1 is incubated with virus-infected GS cells on ice, and the infected cells are collected after high-temperature denaturation and recovered to supernatant 2, and then mixed with Normal cells were incubated on ice, so as to remove non-specific single-stranded DNA combined with normal cells to the greatest extent, and achieve the purpose of improving screening efficiency.
与现有的技术相比,本发明的优点在于:本发明通过优化的细胞SELEX筛选得到的核酸适配体,与现有的蛋白抗体相比具有更高的亲和力和特异性,而且还具有蛋白抗体所不具备的特点,包括无免疫原性;分子量小,便于体外化学合成;易于对核酸适配体的不同部位进行修饰和取代;序列稳定易于运输和保存;制备周期短,重现性好;便于标记等。采用本发明的核酸适配体进行石斑鱼虹彩病毒的感染检测时,操作简单迅速,可以在细胞水平和组织水平上检测到虹彩病毒的感染,解离常数均在纳摩尔范围以内,并应用于相关的检测试剂盒。这对于虹彩病毒感染的快速检测具有重要意义,在虹彩病毒感染的检测领域有良好的应用前景。Compared with the existing technology, the advantage of the present invention is that the nucleic acid aptamer screened by the optimized cell SELEX of the present invention has higher affinity and specificity than the existing protein antibody, and also has protein The characteristics that antibodies do not have include non-immunogenicity; small molecular weight, which is convenient for chemical synthesis in vitro; easy to modify and replace different parts of nucleic acid aptamers; stable sequence, easy to transport and store; short preparation period and good reproducibility ; Easy to mark, etc. When the nucleic acid aptamer of the present invention is used to detect the infection of grouper iridescent virus, the operation is simple and fast, and the infection of iridescent virus can be detected at the cell level and tissue level, and the dissociation constants are all within the nanomolar range, and the application related detection kits. This is of great significance for the rapid detection of iridescent virus infection, and has a good application prospect in the field of detection of iridescent virus infection.
附图说明:Description of drawings:
图1是本发明实施例中流式细胞仪检测异硫氰酸荧光素(FITC)标记的第9轮、10轮、11轮、12轮、13轮、14轮筛选文库与被虹彩病毒感染的GS细胞的结合情况,其中,A为感染SGIV的GS靶细胞,B为正常的GS对照细胞;Fig. 1 is the 9th round, 10th round, 11th round, 12th round, 13th round, 14th round of screening library and GS infected by iridescent virus in flow cytometer detection fluorescein isothiocyanate (FITC) label in the embodiment of the invention The combination of cells, wherein, A is the GS target cell infected with SGIV, and B is the normal GS control cell;
图2是本发明实施例中流式细胞仪检测筛选得到的异硫氰酸荧光素(FITC)标记的序列1的核酸适配体与被虹彩病毒感染的GS细胞结合能力的检测结果;Fig. 2 is the detection result of the nucleic acid aptamer of the fluorescein isothiocyanate (FITC)-labeled sequence 1 obtained by flow cytometry detection and screening in the embodiment of the present invention and the GS cell infected by iridovirus;
图3是本发明实施例中羧基四甲基罗丹明(TAMRA)标记的序列1的核酸适配体与被虹彩病毒感染的GS细胞、正常GS细胞染色荧光强度差异比较(图中的两组图片,左边是明场的成像,右边是荧光通道的成像,是同一照片中不同通道的信息);Fig. 3 is the nucleic acid aptamer of carboxytetramethylrhodamine (TAMRA) labeled sequence 1 in the embodiment of the present invention and the GS cell that is infected by iridescent virus, normal GS cell dyeing fluorescent intensity difference comparison (two groups of pictures in the figure , the left is the image of bright field, and the right is the image of fluorescence channel, which is the information of different channels in the same photo);
图4是本发明实施例中羧基四甲基罗丹明(TAMRA)标记的序列1的核酸适配体与被虹彩病毒感染的石斑鱼肝脏组织、正常石斑鱼肝脏组织染色荧光强度差异比较(图中的两组图片,左边是明场的成像,右边是荧光通道的成像,是同一照片中不同通道的信息)。Fig. 4 is the nucleic acid aptamer of carboxytetramethylrhodamine (TAMRA)-labeled sequence 1 in the embodiment of the present invention and the grouper liver tissue that is infected by iridescent virus, the normal grouper liver tissue staining fluorescent intensity difference comparison ( In the two groups of pictures in the figure, the left side is the imaging of bright field, and the right side is the imaging of fluorescence channel, which is the information of different channels in the same picture).
具体实施方式:Detailed ways:
以下实施例是对本发明的进一步说明,而不是对本发明的限制。以下实施例中的实验方法如无特殊说明,均为常规方法。以下实施例中的实验材料如无特殊说明,均是从常规的生化试剂公司购买所得到。The following examples are to further illustrate the present invention, rather than limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. Unless otherwise specified, the experimental materials in the following examples were purchased from conventional biochemical reagent companies.
实施例1:Example 1:
1、合成以下序列所示的随机单链DNA文库和引物1. Synthesize the random single-stranded DNA library and primers shown in the following sequence
随机文库Library50:Random library Library50:
5’-GACGCTTACTCAGGTGTGACTCG(50N)CGAAGGACGCAGATGAAGTCTC5'-GACGCTTACTCAGGTGTGACTCG(50N)CGAAGGACGCAGATGAAGTCTC
5’引物:5’-FITC-GACGCTTACTCAGGTGTGACTCG-3’;5' primer: 5'-FITC-GACGCTTACTCAGGTGTGACTCG-3';
5’引物:5’-TAMRA-GACGCTTACTCAGGTGTGACTCG-3’;5' primer: 5'-TAMRA-GACGCTTACTCAGGTGTGACTCG-3';
3’引物:5’-Biotin-GAGACTTCATCTGCGTCCTTCG-3’;3' primer: 5'-Biotin-GAGACTTCATCTGCGTCCTTCG-3';
2、Cell-SELEX筛选获得特异性识别被SGIV感染的GS细胞的核酸适配体2. Cell-SELEX screening to obtain nucleic acid aptamers that specifically recognize SGIV-infected GS cells
2.1L15培养基中加入10%胎牛血清培养GS细胞至铺满培养瓶底95%,在培养瓶中加入石斑鱼虹彩病毒(SGIV),石斑鱼虹彩病毒感染正常的石斑鱼脾细胞GS细胞,继续培养48h后,去除被病毒感染的细胞的培养瓶中的培养基,用15ml PBS洗涤被感染的GS细胞;2.1 Add 10% fetal calf serum to the 1L15 medium to cultivate GS cells until 95% of the bottom of the culture bottle is covered, add grouper iridescent virus (SGIV) to the culture bottle, and grouper iridescent virus infects normal grouper splenocytes GS cells, after continuing to cultivate for 48h, remove the medium in the culture flask of the cells infected by the virus, and wash the infected GS cells with 15ml of PBS;
2.2将10nmol上述随机文库溶解在300μl binding buffer中,95℃恒温水浴5min,然后迅速插入冰中,冰浴10min,用binding buffer补充至1mL,将处理后的随机文库与2.1中被SGIV感染的GS细胞在冰上孵育1h;2.2 Dissolve 10nmol of the above random library in 300μl binding buffer, bathe in constant temperature water at 95°C for 5min, then quickly insert it into ice, bath in ice for 10min, supplement to 1mL with binding buffer, mix the processed random library with the GS infected by SGIV in 2.1 Cells were incubated on ice for 1 h;
2.3孵育结合完成后,将培养瓶中的液体除去,用10mL的PBS洗涤培养瓶中细胞;用细胞刮刀将细胞刮下并混匀在1mL PBS中,将细胞混液转移到EP管中,94℃恒温水浴5min,12000g离心收集上清,即为感染SGIV的GS细胞的特异核酸适配体库。2.3 After incubation and binding, remove the liquid in the culture flask, wash the cells in the culture flask with 10 mL of PBS; scrape off the cells with a cell scraper and mix them in 1 mL of PBS, transfer the cell mixture to an EP tube and store at 94°C The supernatant was collected by centrifugation at 12000 g for 5 minutes in a constant temperature water bath, which was the specific nucleic acid aptamer library of GS cells infected with SGIV.
3、PCR扩增筛选文库3. PCR amplification screening library
取200μl筛选得到的感染SGIV的GS细胞的特异核酸适配体库进行PCR扩增,具体的扩增条程序是:94℃2min,94℃1min,60℃30sec,72℃1min,经过12轮循环,72℃5min。第一轮筛选后得到的上清,要全部用于进行PCR扩增,得到扩增产物。Take 200 μl of the screened specific nucleic acid aptamer library of GS cells infected with SGIV for PCR amplification. The specific amplification program is: 94°C for 2min, 94°C for 1min, 60°C for 30sec, 72°C for 1min, after 12 cycles , 72°C for 5min. The supernatant obtained after the first round of screening should all be used for PCR amplification to obtain amplification products.
4、DNA单链文库的制备4. Preparation of single-stranded DNA library
将100μl链酶亲和素标记的磁珠与步骤3中PCR扩增所得的双链DNA在常温下孵育30min,利用双链DNA上的生物素与磁珠上链酶亲和素的亲和作用,将双链DNA结合到磁珠表面,将EP管放在磁性分离器上除去上清,用1mLPBS洗涤磁珠,然后在EP管中加入400ul 200mM NaOH溶液,常温反应15min,利用磁性分离架回收得到上清;除盐柱用10mL无菌水洗涤后,将上清液加入除盐柱,靠重力作用自然滴完。加入1mL无菌水,收集到含有DNA单链文库的溶液。Incubate 100 μl of streptavidin-labeled magnetic beads with the double-stranded DNA amplified by PCR in step 3 for 30 min at room temperature, using the affinity between the biotin on the double-stranded DNA and the streptavidin on the magnetic beads , bind the double-stranded DNA to the surface of the magnetic beads, put the EP tube on the magnetic separator to remove the supernatant, wash the magnetic beads with 1mL of PBS, then add 400ul 200mM NaOH solution to the EP tube, react at room temperature for 15min, and recover with the magnetic separation rack Obtain the supernatant; wash the desalting column with 10 mL of sterile water, add the supernatant to the desalting column, and drop it naturally by gravity. Add 1 mL of sterile water to collect a solution containing a DNA single-stranded library.
5、如上反复筛选5. Repeated screening as above
将步骤4中得到的DNA单链文库代替步骤(2)中的随机文库,重复步骤2-4所示的阳性筛选过程、PCR扩增及单链DNA文库的制取过程14次。Replace the random library in step (2) with the DNA single-stranded library obtained in step 4, and repeat the positive screening process, PCR amplification and preparation of the single-stranded DNA library shown in steps 2-4 14 times.
6、阴性筛选6. Negative screening
在第二轮及第二轮以后筛选中,用正常的GS细胞为对照,将步骤5后筛选得到的DNA单链文库进行阴性筛选以提高筛选效率。具体的阴性筛选过程为:培养GS细胞至铺满培养瓶底,用15ml PBS洗涤细胞;将筛选得到的DNA文库溶解、95℃恒温水浴、冰浴后,与经前述处理后的正常GS细胞在冰上孵育0.5h,孵育完成后收集细胞孵育后的溶液;然后将此溶液与被SGIV感染的GS细胞进行冰浴结合1h;将感染SGIV的GS细胞经85~94℃恒温水浴加热2~10min,12000g离心收集到上清1后,再将此上清1与经前述处理后的另一瓶正常GS细胞在冰上孵育1h,收集到的上清2即为经过两次反筛的高特异性识别感染SGIV的GS细胞的核酸适配体。In the second round and after the second round of screening, normal GS cells were used as a control, and the DNA single-stranded library obtained after step 5 was subjected to negative screening to improve the screening efficiency. The specific negative screening process is as follows: culture GS cells until the bottom of the culture flask is covered, and wash the cells with 15ml PBS; dissolve the DNA library obtained by screening, put it in a constant temperature water bath at 95°C, and put it in an ice bath, and mix it with the normal GS cells treated above Incubate on ice for 0.5h, collect the cell incubation solution after the incubation is completed; then combine this solution with SGIV-infected GS cells in an ice bath for 1 hour; heat the SGIV-infected GS cells in a constant temperature water bath at 85-94°C for 2-10 minutes , 12000g centrifugation to collect supernatant 1, then incubate this supernatant 1 with another bottle of normal GS cells after the above-mentioned treatment on ice for 1 hour, and the collected supernatant 2 is the high-specificity cell that has been reversed twice. Aptamers that recognize SGIV-infected GS cells.
7、15轮筛选7. 15 rounds of screening
将步骤6中收集到的上清溶液,经过步骤3的PCR扩增和步骤4的单链DNA文库制备后,依次重复进行步骤6、步骤2、步骤3和步骤4的过程,利用流式细胞术检测所得文库对感染SGIV的GS细胞识别能力的增强情况,与第一轮筛选的正常细胞数目相比,将筛选过程中正常GS细胞的数目提高2-6倍,与第一轮筛选的文库与细胞的结合时间相比,在随后的筛选过程中,文库与正常GS细胞结合时间从0.5h增加至1h,文库与病毒感染细胞结合时间从1h缩短至0.5h,以提高每轮的筛选效率,直至15轮筛选后,文库对被感染SGIV的GS细胞识别能力达到最强。将所得扩增产物经克隆测序分析后,最终得到本实施例的1条可用于检测SGIV感染的核酸适配体,序列如SEQ ID NO:1所示。With the supernatant solution collected in step 6, after the PCR amplification in step 3 and the preparation of the single-stranded DNA library in step 4, repeat the process of step 6, step 2, step 3 and step 4 in sequence, and use flow cytometry Compared with the number of normal cells in the first round of screening, the number of normal GS cells in the screening process was increased by 2-6 times, compared with the library of the first round of screening. Compared with the binding time of cells, in the subsequent screening process, the binding time of the library and normal GS cells was increased from 0.5h to 1h, and the binding time of the library and virus-infected cells was shortened from 1h to 0.5h to improve the screening efficiency of each round , until after 15 rounds of screening, the ability of the library to recognize GS cells infected with SGIV reached the strongest. After the obtained amplified product was analyzed by cloning and sequencing, a nucleic acid aptamer of this embodiment that can be used to detect SGIV infection was finally obtained, the sequence of which is shown in SEQ ID NO: 1.
8、利用流式细胞术检测筛选过程中核酸适配体文库的富集情况8. Using flow cytometry to detect the enrichment of the nucleic acid aptamer library during the screening process
将感染SGIV的GS细胞用无酶消化液处理,1000g离心除去上清,用5mLPBS离心洗涤三次。将300nM异硫氰酸荧光素(FITC)标记的第9轮、10轮、11轮、12轮、13轮、14轮筛选文库溶于1mL的binding buffer中,然后与经上述处理后的细胞在冰上孵育结合30min,1000g离心去上清,用5mLPBS离心洗涤三次,最终将细胞混匀在500μl PBS中,用于流式细胞仪检测。以与Library结合的细胞为对照1,以各轮文库与正常GS细胞的结合为对照2,检测结果如图1所示。该结果证实,经过14轮的筛选,得到的筛选文库对感染SGIV的GS靶细胞具有较强的特异性识别能力(图1A),而对正常的GS对照细胞无识别(图1B)。The GS cells infected with SGIV were treated with enzyme-free digestion solution, the supernatant was removed by centrifugation at 1000g, and washed three times with 5mL PBS. Dissolve 300 nM fluorescein isothiocyanate (FITC)-labeled round 9, round 10, round 11, round 12, round 13, and round 14 of the screening library in 1 mL of binding buffer, and then mix with the above-mentioned treated cells in Incubate on ice for 30min, centrifuge at 1000g to remove the supernatant, wash with 5mL PBS three times, and finally mix the cells in 500μl PBS for flow cytometry detection. The cells combined with Library were used as control 1, and the combination of each round of library with normal GS cells was used as control 2. The detection results are shown in Figure 1. The results confirmed that after 14 rounds of screening, the screening library obtained had strong specific recognition ability for GS target cells infected with SGIV ( FIG. 1A ), but had no recognition for normal GS control cells ( FIG. 1B ).
9、利用流式细胞术检测本实施例中四条异硫氰酸荧光素(FITC)标记的核酸适配体对感染SGIV的GS细胞的结合效果及其特异性9. Using flow cytometry to detect the binding effect and specificity of the four fluorescein isothiocyanate (FITC)-labeled aptamers in this example to GS cells infected with SGIV
细胞的处理、细胞与核酸适配体的孵育结合过程如上述所示,流式细胞术的检测结果如图2所示,结果证实,序列1的核酸适配体均对靶细胞感染SGIV的GS细胞具有较强的特异性识别能力。The treatment of cells, the incubation and binding process of cells and nucleic acid aptamers are as described above, and the detection results of flow cytometry are shown in Figure 2. The results confirm that the nucleic acid aptamers of sequence 1 are all effective against the target cells infected with the GS of SGIV. Cells have strong specific recognition ability.
10、荧光显微镜检测本实施例中四条羧基四甲基罗丹明(TAMRA)标记的核酸适配体与感染SGIV的GS细胞的结合效果及其特异性10. Detection of the binding effect and specificity of the four carboxytetramethylrhodamine (TAMRA)-labeled nucleic acid aptamers in this example and GS cells infected with SGIV by fluorescence microscope
在六孔板中的盖玻片上培养GS细胞,接入SGIV后继续培养48h,获得感染SGIV的GS细胞细胞,在另一盖玻片上培养正常GS细胞作为对照,去除培养基,用10mL PBS洗涤细胞。加入含有300nM上述本实施例中的核酸适配体的1mL binding buffer,冰浴结合30min。反应结束后,去除上清,用10mL PBS清洗三次,略干燥后,将盖玻片放在载玻片上用抗荧光淬灭剂封片,观察。如图3所示,序列1的核酸适配体均对感染SGIV的GS细胞具有特异性结合能力,而对正常GS细胞几乎没有结合能力,该结果与流式细胞仪的检测结果一致。Culture GS cells on a cover glass in a six-well plate, continue to culture for 48 hours after being inserted into SGIV, and obtain GS cells infected with SGIV, and culture normal GS cells on another cover glass as a control, remove the medium, and wash with 10 mL PBS cell. Add 1mL binding buffer containing 300nM nucleic acid aptamer in this example above, and bind in ice bath for 30min. After the reaction, remove the supernatant, wash three times with 10mL PBS, dry slightly, put the coverslip on a glass slide and seal with anti-fluorescence quenching agent for observation. As shown in Figure 3, the nucleic acid aptamers of sequence 1 all have specific binding ability to GS cells infected with SGIV, but have almost no binding ability to normal GS cells, which is consistent with the detection results of flow cytometry.
11、核酸适配体对被虹彩病毒感染的石斑鱼肝脏组织的特异性结合测试11. Specific binding test of nucleic acid aptamer to grouper liver tissue infected by iridovirus
用羧基四甲基罗丹明(TAMRA)标记的序列1核酸适配体,对感染SGIV的石斑鱼肝脏组织冰冻切片进行特异性结合检测,将核酸适配体与正常石斑鱼肝脏组织冰冻切片的结合结果作为对照。首先将冰冻切片用100mL PBS洗涤3次,将切片与200μl含有300nM TAMRA标记的核酸适配体的binding buffer室温孵育结合60min,然后将组织放在摇床上用100mLPBS洗涤,对照正常组织的染色和洗涤方法相同。待组织略干燥后,用抗荧光淬灭剂封片,在荧光显微镜下观察。如图4所示,序列1所示的核酸适配体均对感染SGIV的石斑鱼肝脏组织具有较强的特异性结合能力,而对正常石斑鱼肝脏组织几乎没有结合能力。这与感染SGIV的石斑鱼细胞的荧光显微镜观察结果和流式细胞仪检测结果一致。Carboxytetramethylrhodamine (TAMRA)-labeled Sequence 1 nucleic acid aptamer was used to detect specific binding on frozen sections of grouper liver tissue infected with SGIV, and the nucleic acid aptamer was combined with normal grouper liver tissue frozen sections The combined results were used as a control. First wash the frozen section with 100mL PBS for 3 times, then incubate the section with 200μl binding buffer containing 300nM TAMRA-labeled nucleic acid aptamer at room temperature for 60min, then wash the tissue on a shaker with 100mL PBS, and compare the staining and washing of normal tissue The method is the same. After the tissue was slightly dry, the slide was sealed with anti-fluorescence quenching agent and observed under a fluorescence microscope. As shown in Figure 4, the nucleic acid aptamers shown in Sequence 1 all have strong specific binding ability to the liver tissue of the grouper infected with SGIV, but have almost no binding ability to the liver tissue of the normal grouper. This is consistent with the results of fluorescence microscopy and flow cytometry of grouper cells infected with SGIV.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510125806.8A CN104789569B (en) | 2015-03-20 | 2015-03-20 | A kind of DNA aptamers and its screening technique and application for being used to detect grouper irido virus infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510125806.8A CN104789569B (en) | 2015-03-20 | 2015-03-20 | A kind of DNA aptamers and its screening technique and application for being used to detect grouper irido virus infection |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104789569A true CN104789569A (en) | 2015-07-22 |
CN104789569B CN104789569B (en) | 2017-11-21 |
Family
ID=53554763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510125806.8A Active CN104789569B (en) | 2015-03-20 | 2015-03-20 | A kind of DNA aptamers and its screening technique and application for being used to detect grouper irido virus infection |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104789569B (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105785024A (en) * | 2016-04-22 | 2016-07-20 | 中国科学院南海海洋研究所 | Aptamer-based enzyme-linked immunosorbent assay method for detecting iridovirus infection of groupers |
CN109161547A (en) * | 2018-09-20 | 2019-01-08 | 广西科学院 | A kind of aptamer and its application in the pathogenic vibrio alginolyticus of detection |
CN109161548A (en) * | 2018-09-26 | 2019-01-08 | 广西科学院 | Aptamer and its application in detection egg-shaped pompano source nervous necrosis virus |
CN110643611A (en) * | 2019-10-30 | 2020-01-03 | 广西科学院 | A kind of nucleic acid aptamer and its construction method and its application in detecting grouper iridovirus |
CN111073891A (en) * | 2019-10-30 | 2020-04-28 | 广西科学院 | A nucleic acid aptamer for detecting grouper iridovirus and its construction method and application |
CN111118014A (en) * | 2019-10-30 | 2020-05-08 | 广西科学院 | A kind of nucleic acid aptamer against iris virus and its construction method and application |
CN111363748A (en) * | 2020-02-07 | 2020-07-03 | 广西科学院 | A kind of nucleic acid aptamer and its construction method and its application in the detection of Chinese soft-shelled turtle rainbow virus |
CN111363749A (en) * | 2020-02-07 | 2020-07-03 | 广西科学院 | Aptamer for detecting Chinese softshell turtle iridovirus and construction method and application thereof |
CN113278621A (en) * | 2021-05-14 | 2021-08-20 | 广西科学院 | ssDNA aptamer and application thereof in identification and detection of vibrio harveyi |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0524808A2 (en) * | 1991-07-23 | 1993-01-27 | F. Hoffmann-La Roche Ag | In situ PCR preparations, their use, and corresponding thermal cycler equipment |
EP0530112B1 (en) * | 1991-08-30 | 2003-06-25 | University Of Medicine And Dentistry Of New Jersey | Method for synthesizing singlestranded stem-loop DNAS |
CN1827778A (en) * | 2005-03-02 | 2006-09-06 | 国家海洋局第三海洋研究所 | Real-time fluorescence quantitative PCR detection method for fish iridovirus |
CN101173317A (en) * | 2007-09-26 | 2008-05-07 | 中山大学 | A method for rapid detection of grouper iridescent virus |
CN102727879A (en) * | 2012-07-11 | 2012-10-17 | 中国科学院南海海洋研究所 | Spinner bottle production method of inactivated singapore grouper iridovirus (SGIV) vaccine |
-
2015
- 2015-03-20 CN CN201510125806.8A patent/CN104789569B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0524808A2 (en) * | 1991-07-23 | 1993-01-27 | F. Hoffmann-La Roche Ag | In situ PCR preparations, their use, and corresponding thermal cycler equipment |
EP0530112B1 (en) * | 1991-08-30 | 2003-06-25 | University Of Medicine And Dentistry Of New Jersey | Method for synthesizing singlestranded stem-loop DNAS |
CN1827778A (en) * | 2005-03-02 | 2006-09-06 | 国家海洋局第三海洋研究所 | Real-time fluorescence quantitative PCR detection method for fish iridovirus |
CN101173317A (en) * | 2007-09-26 | 2008-05-07 | 中山大学 | A method for rapid detection of grouper iridescent virus |
CN102727879A (en) * | 2012-07-11 | 2012-10-17 | 中国科学院南海海洋研究所 | Spinner bottle production method of inactivated singapore grouper iridovirus (SGIV) vaccine |
Non-Patent Citations (2)
Title |
---|
PENGFEI LI ET AL.: "Isolation and characterization of a new class of DNA aptamers specific binding to Singapore grouper iridovirus (SGIV) with antiviral activities", 《VIRUS RESEARCH》 * |
梁红茹: "狂犬病毒核酸适配体的筛选及其生物学活性鉴定", 《中国博士学位论文全文数据库 农业科技辑》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105785024A (en) * | 2016-04-22 | 2016-07-20 | 中国科学院南海海洋研究所 | Aptamer-based enzyme-linked immunosorbent assay method for detecting iridovirus infection of groupers |
CN109161547B (en) * | 2018-09-20 | 2021-11-09 | 广西科学院 | Nucleic acid aptamer and application thereof in detection of pathogenic vibrio alginolyticus |
CN109161547A (en) * | 2018-09-20 | 2019-01-08 | 广西科学院 | A kind of aptamer and its application in the pathogenic vibrio alginolyticus of detection |
CN109161548A (en) * | 2018-09-26 | 2019-01-08 | 广西科学院 | Aptamer and its application in detection egg-shaped pompano source nervous necrosis virus |
CN110643611A (en) * | 2019-10-30 | 2020-01-03 | 广西科学院 | A kind of nucleic acid aptamer and its construction method and its application in detecting grouper iridovirus |
CN111118014A (en) * | 2019-10-30 | 2020-05-08 | 广西科学院 | A kind of nucleic acid aptamer against iris virus and its construction method and application |
CN111073891A (en) * | 2019-10-30 | 2020-04-28 | 广西科学院 | A nucleic acid aptamer for detecting grouper iridovirus and its construction method and application |
CN110643611B (en) * | 2019-10-30 | 2022-10-28 | 广西科学院 | Aptamer, construction method thereof and application thereof in detection of grouper iridovirus |
CN111073891B (en) * | 2019-10-30 | 2022-10-28 | 广西科学院 | A nucleic acid aptamer for detecting grouper iridovirus and its construction method and application |
CN111118014B (en) * | 2019-10-30 | 2022-12-20 | 广西科学院 | A kind of anti-iridovirus nucleic acid aptamer and its construction method and application |
CN111363748A (en) * | 2020-02-07 | 2020-07-03 | 广西科学院 | A kind of nucleic acid aptamer and its construction method and its application in the detection of Chinese soft-shelled turtle rainbow virus |
CN111363749A (en) * | 2020-02-07 | 2020-07-03 | 广西科学院 | Aptamer for detecting Chinese softshell turtle iridovirus and construction method and application thereof |
CN111363748B (en) * | 2020-02-07 | 2022-12-20 | 广西科学院 | Aptamer, construction method thereof and application thereof in detection of Chinese softshell turtle rainbow virus |
CN111363749B (en) * | 2020-02-07 | 2022-12-20 | 广西科学院 | A nucleic acid aptamer for detecting Chinese soft-shelled turtle iridescent virus and its construction method and application |
CN113278621A (en) * | 2021-05-14 | 2021-08-20 | 广西科学院 | ssDNA aptamer and application thereof in identification and detection of vibrio harveyi |
Also Published As
Publication number | Publication date |
---|---|
CN104789569B (en) | 2017-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104789568B (en) | A kind of DNA aptamers and its screening technique and application for being used to detect grouper irido virus infection | |
CN104789696B (en) | A kind of DNA aptamers and its screening technique and application for being used to detect grouper irido virus infection | |
CN104789569B (en) | A kind of DNA aptamers and its screening technique and application for being used to detect grouper irido virus infection | |
CN108034659B (en) | A kind of ssDNA nucleic acid aptamer and its application in rapid detection of Vibrio alginolyticus | |
CN111073892B (en) | Nucleic acid aptamer for identifying garrupa iridovirus infected cells, construction method and application thereof | |
CN113215167B (en) | Nucleic acid aptamers and their application in detecting largemouth bass iridovirus-infected cells | |
CN111073891B (en) | A nucleic acid aptamer for detecting grouper iridovirus and its construction method and application | |
CN107858358B (en) | A ssDNA nucleic acid aptamer capable of recognizing and binding to Vibrio alginolyticus and its application | |
CN103205431A (en) | Nucleic acid aptamer and derivatives thereof, screening method of nucleic acid aptamer, application of nucleic acid aptamer and derivatives in detecting human biliary duct carcinoma cell line | |
CN110643611B (en) | Aptamer, construction method thereof and application thereof in detection of grouper iridovirus | |
CN102766693B (en) | Nucleic acid aptamer for detecting human hepatoma cell line SMMC-7721 as well as screening method and application thereof | |
CN109161547B (en) | Nucleic acid aptamer and application thereof in detection of pathogenic vibrio alginolyticus | |
CN107858359B (en) | A nucleic acid aptamer that can specifically recognize Vibrio alginolyticus and its application | |
CN104789570B (en) | A kind of DNA aptamers for being used to detect grouper irido virus infection and its screening technique and application | |
CN109136229B (en) | Nucleic acid aptamer for specific recognition of oval pomfret-derived neuronecrosis virus and its application | |
CN102766633B (en) | DNA (deoxyribonucleic acid) aptamer available for detecting HCC (hepatocellular carcinoma) cell line Bel-7404 and screening method and application thereof | |
CN111454956B (en) | Nucleic acid aptamer for Chinese soft-shelled turtle iridovirus as well as construction method and application thereof | |
CN111363749B (en) | A nucleic acid aptamer for detecting Chinese soft-shelled turtle iridescent virus and its construction method and application | |
CN107937404B (en) | A nucleic acid aptamer and its application in identifying and detecting Vibrio alginolyticus | |
CN109207480B (en) | Aptamer specific for trachinotus ovatus nervous necrosis virus and application thereof | |
CN108004240B (en) | A kind of ssDNA nucleic acid aptamer specific for Vibrio alginolyticus and its application | |
CN111118014B (en) | A kind of anti-iridovirus nucleic acid aptamer and its construction method and application | |
CN109161548B (en) | Aptamer and application thereof in detection of trachinotus ovatus-derived nervous necrosis virus | |
CN113278621B (en) | ssDNA aptamer and application thereof in identification and detection of vibrio harveyi | |
RU2013143490A (en) | METHOD FOR DETECTING CIRCULATING TUMOR CELLS, MICROEMBOL AND APOPTOTIC BODIES IN BLOOD OF LUNG CANCER PATIENTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |